SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM
P080402
Phase 3 small_molecule completed
Quick answer
SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM for Amyotrophic Lateral Sclerosis is a Phase 3 program (small_molecule) at ARS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARS Pharmaceuticals
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed